Jesse W. Wotring

775 total citations
10 papers, 204 citations indexed

About

Jesse W. Wotring is a scholar working on Infectious Diseases, Molecular Biology and Pharmacology. According to data from OpenAlex, Jesse W. Wotring has authored 10 papers receiving a total of 204 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 5 papers in Molecular Biology and 2 papers in Pharmacology. Recurrent topics in Jesse W. Wotring's work include SARS-CoV-2 and COVID-19 Research (6 papers), Biochemical and Structural Characterization (2 papers) and Microbial Natural Products and Biosynthesis (2 papers). Jesse W. Wotring is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (6 papers), Biochemical and Structural Characterization (2 papers) and Microbial Natural Products and Biosynthesis (2 papers). Jesse W. Wotring collaborates with scholars based in United States, Netherlands and Germany. Jesse W. Wotring's co-authors include Jonathan Z. Sexton, Loren S. Ward, Lisa S. Mydy, Roland D. Kersten, Timothy Fallon, Marnix H. Medema, Satria A. Kautsar, Jing‐Ke Weng, Wenjie Li and Ashootosh Tripathi and has published in prestigious journals such as Journal of the American Chemical Society, PLoS ONE and Scientific Reports.

In The Last Decade

Jesse W. Wotring

10 papers receiving 198 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jesse W. Wotring United States 8 110 62 55 29 25 10 204
Waqasuddin Khan Pakistan 10 139 1.3× 45 0.7× 51 0.9× 9 0.3× 37 1.5× 27 271
Yukiko Miyazaki Japan 10 79 0.7× 13 0.2× 45 0.8× 42 1.4× 13 0.5× 27 245
Gefei He China 8 51 0.5× 45 0.7× 102 1.9× 7 0.2× 7 0.3× 22 278
Bing Peng China 6 121 1.1× 13 0.2× 111 2.0× 89 3.1× 16 0.6× 10 320
Tamina Park South Korea 9 93 0.8× 19 0.3× 30 0.5× 12 0.4× 51 2.0× 16 287
Eugene P. Kadar United States 9 75 0.7× 41 0.7× 118 2.1× 5 0.2× 15 0.6× 16 302
Adekunle Babajide Rowaiye Nigeria 8 90 0.8× 38 0.6× 75 1.4× 16 0.6× 3 0.1× 36 242
Oyekanmi Nash Nigeria 9 74 0.7× 14 0.2× 64 1.2× 14 0.5× 20 0.8× 24 241
Jovica Ralić Croatia 7 78 0.7× 31 0.5× 15 0.3× 12 0.4× 26 1.0× 10 219
Mustafa Alhaji Isa Nigeria 9 88 0.8× 21 0.3× 29 0.5× 17 0.6× 45 1.8× 34 221

Countries citing papers authored by Jesse W. Wotring

Since Specialization
Citations

This map shows the geographic impact of Jesse W. Wotring's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jesse W. Wotring with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jesse W. Wotring more than expected).

Fields of papers citing papers by Jesse W. Wotring

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jesse W. Wotring. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jesse W. Wotring. The network helps show where Jesse W. Wotring may publish in the future.

Co-authorship network of co-authors of Jesse W. Wotring

This figure shows the co-authorship network connecting the top 25 collaborators of Jesse W. Wotring. A scholar is included among the top collaborators of Jesse W. Wotring based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jesse W. Wotring. Jesse W. Wotring is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Wu, Yujin, Jesse W. Wotring, Sahil Arora, et al.. (2023). TMPRSS2 Inhibitor Discovery Facilitated through an In Silico and Biochemical Screening Platform. ACS Medicinal Chemistry Letters. 14(6). 860–866. 10 indexed citations
2.
Qiao, Yuanyuan, Jesse W. Wotring, Charles J. Zhang, et al.. (2023). Antisense oligonucleotides to therapeutically target SARS-CoV-2 infection. PLoS ONE. 18(2). e0281281–e0281281. 11 indexed citations
3.
O’Meara, Matthew J., et al.. (2023). Imaging-Based Screening Identifies Modulators of the eIF3 Translation Initiation Factor Complex in Candida albicans. Antimicrobial Agents and Chemotherapy. 67(7). e0050323–e0050323. 3 indexed citations
4.
Mirabelli, Carmen, Juliana Bragazzi Cunha, Jesse W. Wotring, et al.. (2023). ARF6 is a host factor for SARS-CoV-2 infection in vitro. Journal of General Virology. 104(6). 7 indexed citations
5.
Wotring, Jesse W., Charles J. Zhang, Carmen Mirabelli, et al.. (2022). In Vitro Evaluation and Mitigation of Niclosamide’s Liabilities as a COVID-19 Treatment. Vaccines. 10(8). 1284–1284. 3 indexed citations
6.
Yao, Yi, Kalpana Subedi, Tingting Liu, et al.. (2022). Surface translocation of ACE2 and TMPRSS2 upon TLR4/7/8 activation is required for SARS-CoV-2 infection in circulating monocytes. Cell Discovery. 8(1). 89–89. 13 indexed citations
7.
Chan, Wallace, et al.. (2022). In silico analysis of SARS-CoV-2 proteins as targets for clinically available drugs. Scientific Reports. 12(1). 5320–5320. 19 indexed citations
8.
Wotring, Jesse W., et al.. (2022). Evaluating the in vitro efficacy of bovine lactoferrin products against SARS-CoV-2 variants of concern. Journal of Dairy Science. 105(4). 2791–2802. 40 indexed citations
9.
Kersten, Roland D., Lisa S. Mydy, Timothy Fallon, et al.. (2022). Gene-Guided Discovery and Ribosomal Biosynthesis of Moroidin Peptides. Journal of the American Chemical Society. 144(17). 7686–7692. 36 indexed citations
10.
Mydy, Lisa S., Wenjie Li, Jesse W. Wotring, et al.. (2021). Discovery and biosynthesis of cyclic plant peptides via autocatalytic cyclases. Nature Chemical Biology. 18(1). 18–28. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026